Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

TPG's Ashley Kosciolek accepted a free trip from Viking Cruises to sail on Viking Mississippi. The opinions expressed below ...

More Viking Age silver has been discovered per square kilometer on the Isle of Man than in England, Ireland, Scotland, and ...

Fintel reports that on November 12, 2024, Morgan Stanley upgraded their outlook for Viking Holdings (NYSE:VIK) from ...

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

Ship-shaped graves have been identified at the site, which came to light during investigations of an earlier Stone Age ...

Sam Darnold has experienced a career revival his his first season with the Minnesota Vikings.

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

If the Vikings get to the post-season and do well, Darnold as a free agent could cost nearly $40 million a year on a new ...

On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...